Masaaki Kondo Selected Research

Masaaki Kondo Research Topics

Disease

28	Hepatocellular Carcinoma (Hepatoma) 04/2021 - 04/2009
17	Neoplasms (Cancer) 11/2023 - 04/2009
4	Infections 01/2022 - 01/2017
4	Chronic Hepatitis C 03/2021 - 01/2010
3	Fibrosis (Cirrhosis) 03/2021 - 07/2012
3	Neoplasm Metastasis (Metastasis) 03/2015 - 04/2009
2	Hypersensitivity (Allergy) 02/2021 - 01/2017
2	Liver Diseases (Liver Disease) 07/2019 - 10/2015
2	Inflammation (Inflammations) 12/2017 - 02/2012
2	Thrombosis (Thrombus) 01/2017 - 01/2011
2	Necrosis 08/2015 - 08/2014
2	Hemangioma (Angioma) 05/2010 - 04/2009
2	Focal Nodular Hyperplasia 05/2010 - 04/2009
1	Liver Cirrhosis (Hepatic Cirrhosis) 03/2021
1	Diarrhea 02/2021
1	Carcinoma in Situ 01/2020
1	Carcinogenesis 01/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020
1	Pancreatitis 01/2020
1	Peptic Ulcer (Peptic Ulcers) 01/2018
1	Ulcer 01/2018
1	Metaplasia 12/2017
1	Atrophy 12/2013
1	Chronic Hepatitis B 12/2013
1	Liver Failure 12/2013
1	Hepatic Encephalopathy 12/2013
1	Residual Neoplasm 03/2012
1	Liver Neoplasms (Liver Cancer) 02/2012
1	Hypoalbuminemia 02/2012
1	Disease Progression 04/2011
1	Drug-Related Side Effects and Adverse Reactions 04/2011

Drug/Important Bio-Agent (IBA)

10	Sorafenib (BAY 43-9006)FDA Link 10/2019 - 04/2011
7	Contrast MediaIBA 10/2015 - 04/2009
7	perfluorobutane (AI 700)IBA 10/2015 - 04/2009
3	1- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamineIBA 02/2021 - 01/2017
2	Proton Pump InhibitorsIBA 11/2023 - 01/2018
2	lenvatinibIBA 04/2021 - 10/2020
2	Antiviral Agents (Antivirals)IBA 03/2021 - 12/2013
2	Metronidazole (Metric)FDA LinkGeneric 02/2021 - 01/2017
2	Penicillins (Penicillin)FDA Link 02/2021 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 07/2019 - 08/2012
2	Cisplatin (Platino)FDA LinkGeneric 03/2015 - 01/2011
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 05/2013 - 03/2013
2	SonazoidIBA 02/2010 - 04/2009
1	SofosbuvirIBA 03/2021
1	sofosbuvir drug combination ledipasvirIBA 03/2021
1	sitafloxacinIBA 02/2021
1	Nitric Oxide Synthase (NO Synthase)IBA 10/2020
1	Cadherins (E-Cadherin)IBA 01/2020
1	MicroRNAs (MicroRNA)IBA 07/2019
1	Esomeprazole (Nexium)FDA Link 01/2018
1	Complementary RNA (cRNA)IBA 12/2017
1	spasmolytic polypeptideIBA 12/2017
1	CarcinogensIBA 12/2017
1	Messenger RNA (mRNA)IBA 12/2017
1	Conditioned Culture MediaIBA 11/2017
1	JNK Mitogen-Activated Protein KinasesIBA 11/2017
1	acarboxyprothrombin (PIVKA)IBA 01/2017
1	Clarithromycin (Biaxin)FDA LinkGeneric 01/2017
1	N 30IBA 08/2014
1	Ribavirin (Virazole)FDA LinkGeneric 09/2013
1	Proteins (Proteins, Gene)FDA Link 05/2013
1	Serum AlbuminIBA 05/2013
1	Vitamin K FDA Link 05/2013
1	Pentetic Acid (DTPA)FDA LinkGeneric 03/2013
1	GadoliniumIBA 03/2013
1	lentil lectinIBA 08/2012
1	Fetal Proteins (Fetoprotein)IBA 08/2012
1	C-Reactive ProteinIBA 02/2012
1	PowdersIBA 01/2011
1	Indicators and Reagents (Reagents)IBA 04/2010
1	LipidsIBA 02/2010
1	SuspensionsIBA 02/2010
1	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2010

Therapy/Procedure

10	Therapeutics 01/2022 - 02/2010
7	Radiofrequency Ablation 01/2018 - 05/2010
3	Drug Therapy (Chemotherapy) 01/2020 - 03/2015
2	Duration of Therapy 04/2018 - 04/2011
2	Punctures 01/2018 - 08/2014
2	High-Intensity Focused Ultrasound Ablation 12/2013 - 12/2011
2	Microbubbles 02/2010 - 04/2009
1	Microspheres (Microsphere) 08/2015
1	Hemodiafiltration 12/2013
1	Artificial Liver (Bioartificial Liver) 12/2013
1	Plasma Exchange 12/2013